Cargando…
The Role of Vitamin D Oral Supplementation in Insulin Resistance in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Objective: To evaluate the effect of vitamin D supplementation (alone or with co-supplementation) on insulin resistance in patients with polycystic ovary syndrome (PCOS). Methods: We performed a literature search of databases (Medline, Scopus, Web of Knowledge, Cochrane Library) and identified all r...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266903/ https://www.ncbi.nlm.nih.gov/pubmed/30400199 http://dx.doi.org/10.3390/nu10111637 |
_version_ | 1783375943268564992 |
---|---|
author | Łagowska, Karolina Bajerska, Joanna Jamka, Małgorzata |
author_facet | Łagowska, Karolina Bajerska, Joanna Jamka, Małgorzata |
author_sort | Łagowska, Karolina |
collection | PubMed |
description | Objective: To evaluate the effect of vitamin D supplementation (alone or with co-supplementation) on insulin resistance in patients with polycystic ovary syndrome (PCOS). Methods: We performed a literature search of databases (Medline, Scopus, Web of Knowledge, Cochrane Library) and identified all reports of randomized controlled trials (RCTs) published prior to April 2018. We compared the effects of supplementation with vitamin D alone (dose from 1000 IU/d to 60,000 IU/week) or with co-supplements to the administration of placebos in women diagnosed with PCOS. The systematic review and meta-analysis protocol was registered in the International Prospective Register of Systematic Reviews (Prospero) as number CRD42018090572. Main results: Eleven of 345 identified studies were included in the analysis; these involved 601women diagnosed with PCOS. Vitamin D as a co-supplement was found to significantly decrease fasting glucose concentrations and the HOMA-IR value. HOMA-IR also declined significantly when vitamin D was supplemented with a dose lower than 4000 IU/d. Conclusions: Evidence from RCTs suggests that the supplementation of PCOS patients with continuous low doses of vitamin D (<4000 IU/d) or supplementation with vitamin D as a co-supplement may improve insulin sensitivity in terms of the fasting glucose concentration (supplementation with vitamin D in combination with other micronutrients) and HOMA-IR (supplementation with vitamin D in continuous low daily doses or as co-supplement). |
format | Online Article Text |
id | pubmed-6266903 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62669032018-12-06 The Role of Vitamin D Oral Supplementation in Insulin Resistance in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Łagowska, Karolina Bajerska, Joanna Jamka, Małgorzata Nutrients Review Objective: To evaluate the effect of vitamin D supplementation (alone or with co-supplementation) on insulin resistance in patients with polycystic ovary syndrome (PCOS). Methods: We performed a literature search of databases (Medline, Scopus, Web of Knowledge, Cochrane Library) and identified all reports of randomized controlled trials (RCTs) published prior to April 2018. We compared the effects of supplementation with vitamin D alone (dose from 1000 IU/d to 60,000 IU/week) or with co-supplements to the administration of placebos in women diagnosed with PCOS. The systematic review and meta-analysis protocol was registered in the International Prospective Register of Systematic Reviews (Prospero) as number CRD42018090572. Main results: Eleven of 345 identified studies were included in the analysis; these involved 601women diagnosed with PCOS. Vitamin D as a co-supplement was found to significantly decrease fasting glucose concentrations and the HOMA-IR value. HOMA-IR also declined significantly when vitamin D was supplemented with a dose lower than 4000 IU/d. Conclusions: Evidence from RCTs suggests that the supplementation of PCOS patients with continuous low doses of vitamin D (<4000 IU/d) or supplementation with vitamin D as a co-supplement may improve insulin sensitivity in terms of the fasting glucose concentration (supplementation with vitamin D in combination with other micronutrients) and HOMA-IR (supplementation with vitamin D in continuous low daily doses or as co-supplement). MDPI 2018-11-02 /pmc/articles/PMC6266903/ /pubmed/30400199 http://dx.doi.org/10.3390/nu10111637 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Łagowska, Karolina Bajerska, Joanna Jamka, Małgorzata The Role of Vitamin D Oral Supplementation in Insulin Resistance in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
title | The Role of Vitamin D Oral Supplementation in Insulin Resistance in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
title_full | The Role of Vitamin D Oral Supplementation in Insulin Resistance in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
title_fullStr | The Role of Vitamin D Oral Supplementation in Insulin Resistance in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
title_full_unstemmed | The Role of Vitamin D Oral Supplementation in Insulin Resistance in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
title_short | The Role of Vitamin D Oral Supplementation in Insulin Resistance in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
title_sort | role of vitamin d oral supplementation in insulin resistance in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266903/ https://www.ncbi.nlm.nih.gov/pubmed/30400199 http://dx.doi.org/10.3390/nu10111637 |
work_keys_str_mv | AT łagowskakarolina theroleofvitamindoralsupplementationininsulinresistanceinwomenwithpolycysticovarysyndromeasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT bajerskajoanna theroleofvitamindoralsupplementationininsulinresistanceinwomenwithpolycysticovarysyndromeasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT jamkamałgorzata theroleofvitamindoralsupplementationininsulinresistanceinwomenwithpolycysticovarysyndromeasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT łagowskakarolina roleofvitamindoralsupplementationininsulinresistanceinwomenwithpolycysticovarysyndromeasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT bajerskajoanna roleofvitamindoralsupplementationininsulinresistanceinwomenwithpolycysticovarysyndromeasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT jamkamałgorzata roleofvitamindoralsupplementationininsulinresistanceinwomenwithpolycysticovarysyndromeasystematicreviewandmetaanalysisofrandomizedcontrolledtrials |